2
Feb
2015
The Merck Exodus: Where Are the Talented People Going?
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
2
Feb
2015
Implications of the Biotech Boom on the Business and Science of R&D
[Editor’s Note: This post was written by Richard Pops] It is exciting to see the remarkable influx of capital into the biopharmaceutical industry over the past couple of years. More than just refilling depleted coffers, strategic investors are putting more money to work in excellent companies after a long period of relative scarcity. Capital can favorably change the risk profile... Read More
2
Feb
2015
Welcome to the Timmerman Report
Welcome to a new adventure in biotech journalism. After a year in the writer’s cave, the Lee Hood book is well on its way. It can now be converted into a nights and weekends project as I come down the stretch with editing. It has been a wonderful reporting challenge putting such a complicated life under the microscope. But I... Read More